blackwiki - User contributions [en]

Template:Antiemetics

2015-04-23T23:11:08Z

62.192.250.172:

{{Navbox

| name = Antiemetics
| title = [[Antiemetic]]s ([[ATC code A04|A04]])
| state = {{{state|autocollapse}}}
|listclass = hlist

| group1 = [[5-HT3 antagonist|5-HT3 Serotonin ion channel antagonist]]s
| list1 =
* [[Alosetron]]
* [[Azasetron]]
* [[Bemesetron]]
* [[Cilansetron]]
* [[Clozapine]]
* [[Dazopride]]
* [[Dolasetron]]
* [[Granisetron]]
* [[Lerisetron]]
* [[Metoclopramide]]
* [[Mianserin]]
* [[Mirtazapine]]
* [[Olanzapine]]
* [[Ondansetron]]
* [[Palonosetron]]
* [[Quetiapine]]
* [[Ramosetron]]
* [[Ricasetron]]
* [[Tropisetron]]
* [[Zatosetron]]

| group2 = [[Serotonin antagonist|5-HT Serotonin G-protein receptor antagonist]]s
| list2 =
* [[Clozapine]]
* [[Cyproheptadine]]
* [[Hydroxyzine]]
* [[Olanzapine]]
* [[Risperidone]]
* [[Ziprasidone]]

| group3 = [[CB1 receptor|CB1]] [[Agonist]]s ([[Cannabinoid]]s)
| list3 =
* [[Dronabinol]]
* [[Nabilone]]
* [[Nonabine]]
* [[Tetrahydrocannabinol]]

| group4 = [[Dopamine antagonist|D2/D3 Antagonist]]s
| list4 =
* [[Alizapride]]
* [[Bromopride]]
* [[Chlorpromazine]]
* [[Clebopride]]
* [[Domperidone]]
* [[Haloperidol]]
* [[Hydroxyzine]]
* [[Itopride]]
* [[Metoclopramide]]
* [[Metopimazine]]
* [[Prochlorperazine]]
* [[Thiethylperazine]]

| group5 = [[H1 antagonist|H1 antagonists]] ([[Histamine antagonist|Antihistamines]])
| list5 =
* [[Cyclizine]]
* [[Dimenhydrinate]]
* [[Diphenhydramine]]
* [[Hydroxyzine]]
* [[Meclozine]]
* [[Promethazine]]

| group6 = [[Muscarinic acetylcholine receptor|mACh]] [[Receptor_Antagonist|antagonists]] ([[Anticholinergic]]s)
| list6 =
* [[Atropine]]
* [[Diphenhydramine]]
* [[Hydroxyzine]] (very mild)
* [[Hyoscyamine]]
* [[Scopolamine]]

| group7 = [[NK1 receptor antagonist|NK1 Antagonists]]
| list7 =
* [[Aprepitant]]
* [[Casopitant]]
* [[Ezlopitant]]
* [[Fosaprepitant]]
* [[Maropitant]]
* [[Netupitant]]
* [[Vestipitant]]

| group8 = Others
| list8 =
* [[Cerium oxalate]]
* [[Dexamethasone]]
* [[Lorazepam]]
* [[Midazolam]]
* [[Propofol]]
* [[Trimethobenzamide]]

| belowstyle = background: transparent; padding: 0px;
| below = {{Digestive system navs}}

}}<noinclude>
{{collapsible option}}
[[Category:Antiemetics]]
[[Category:Drug_templates by ATC]]
</noinclude>

Template:Antithrombotics

2015-04-13T21:14:38Z

62.192.250.172:

{{Navbox
| name = Antithrombotics
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
| state = {{{state|autocollapse}}}
| bodyclass = hlist

| group1 = [[Antiplatelet drug]]s
| list1 = {{Navbox subgroup

| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
| list1 =
* [[Abciximab]]
* [[Eptifibatide]]
* [[Tirofiban]]
*[[Roxifiban]]
*[[Orbofiban]]

| group2 = [[P2Y12|ADP receptor/P2Y12]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
| list2 =
* [[Thienopyridine]]s
** [[Clopidogrel]]
** [[Prasugrel]]
** [[Ticlopidine]]
* [[Nucleotide]]/[[nucleoside]] analogs
** [[Cangrelor]]
** [[Elinogrel]]
** [[Ticagrelor]]

| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
| list3 =
* [[Beraprost]]
* [[Iloprost]]
* [[Prostacyclin]]
* [[Treprostinil]]

| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
| list4 =
* [[Aspirin|Acetylsalicylic acid/Aspirin]]#
* [[Aloxiprin]]
* [[Carbasalate calcium]]
* [[Indobufen]]
* [[Triflusal]]

| group5 = [[Thromboxane inhibitors]]
| list5 =
* [[Thromboxane synthase inhibitors]]
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
** [[Picotamide]]
* [[Thromboxane receptor antagonist|Receptor antagonist]]s
** [[Terutroban]]†

| group6 = [[Phosphodiesterase inhibitor]]s
| list6 =
* [[Cilostazol]]
* [[Dipyridamole]]
* [[Triflusal]]

| group7 = Other
| list7 =
* [[Cloricromen]]
* [[Ditazole]]
* [[Vorapaxar]]
}}

| group2 = [[Anticoagulant]]s
| list2 = {{Navbox subgroup

| group2 = [[Vitamin K antagonist]]s (inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
| list2 =
* [[Coumarin]]s: [[Acenocoumarol]]
* [[Coumatetralyl]]
* [[Dicoumarol]]
* [[Ethyl biscoumacetate]]
* [[Phenprocoumon]]
* [[Warfarin]]#
* [[1,3-Indandione]]s: [[Clorindione]]
* [[Diphenadione]]
* [[Phenindione]]
* Other: [[Tioclomarol]]

| group3 = [[Factor Xa]] inhibitors (with some II inhibition)
| list3 = {{Navbox subgroup

| group1 = [[Heparin]] group/ [[glycosaminoglycan]]s/ (bind [[antithrombin]])
| list1 =
* [[Low molecular weight heparin]]
** [[Bemiparin sodium|Bemiparin]]
** [[Certoparin sodium|Certoparin]]
** [[Dalteparin sodium|Dalteparin]]
** [[Enoxaparin sodium|Enoxaparin]]
** [[Nadroparin calcium|Nadroparin]]
** [[Parnaparin sodium|Parnaparin]]
** [[Reviparin sodium|Reviparin]]
** [[Tinzaparin sodium|Tinzaparin]]‡
* [[Oligosaccharide]]s
** [[Fondaparinux]]
** [[Idraparinux]]§
* [[Heparinoid]]s
** [[Danaparoid]]
** [[Dermatan sulfate]]
** [[Sulodexide]]

| group2 = [[Direct Xa inhibitor]]s
| list2 =
* Xabans
** [[Apixaban]]
** [[Betrixaban]]§
** [[Darexaban]]§
** [[Edoxaban]]
** [[Otamixaban]]§
** [[Rivaroxaban]]
}}

| group5 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
| list5 =
* [[Direct_thrombin_inhibitor#Bivalent|Bivalent]]: [[Hirudin]]
** [[Bivalirudin]]
** [[Desirudin]]
** [[Lepirudin]]
* [[Direct_thrombin_inhibitor#Univalent|Univalent]]: [[Argatroban]]
* [[Dabigatran]]
* [[Melagatran]]‡
* [[Ximelagatran]]‡

| group6 = Other
| list6 =
* [[Antithrombin|Antithrombin III]]
* [[Defibrotide]]
* [[Protein C]]
** [[Drotrecogin alfa]]‡
* [[Ramatroban]]
* [[REG1]]
}}

| group3 = [[Thrombolytic drug]]s/ [[fibrinolytic]]s
| list3 =
* [[Plasminogen activator]]s: [[recombinant tissue plasminogen activators|r-tPA]]
** [[Tissue plasminogen activator|Alteplase]]
** [[Reteplase]]
** [[Tenecteplase]]
* UPA
** [[Saruplase]]
** [[Urokinase]]
* [[Anistreplase]]
* [[Monteplase]]
* [[Streptokinase]]#
*Other [[serine endopeptidase]]s: [[Ancrod]]
* [[Brinase]]
* [[Fibrinolysin]]

| group4 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
| list4 =
* [[Citrate]]
* [[Ethylenediaminetetraacetic acid|EDTA]]
* [[Oxalate]]

| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}} {{Myeloid navs}}

}}<noinclude>
{{collapsible option}}
[[Category:Antithrombotic agents]]
[[Category:Drug_templates by ATC]]

</noinclude>

Template:Antiretroviral drug

2015-02-26T16:24:57Z

62.192.250.172:

{{Navbox
| name = Antiretroviral drug
| title = [[Antiviral drug]]s: [[antiretroviral drug]]s used against [[HIV]] (primarily [[ATC code J05|J05]])
|listclass = hlist
|state = {{{state<includeonly>|autocollapse</includeonly>}}}

| group1 = [[Entry inhibitor|Entry/fusion inhibitors]] ''([[Discovery and development of CCR5 receptor antagonists|Discovery and development]])''
| list1 =
* ''[[gp41]]'' ([[Enfuvirtide|Enfuvirtide (ENF, T-20)]])
* ''[[CCR5]]'' ([[Maraviroc|Maraviroc (MVC)]]
* [[Vicriviroc]]†, [[Cenicriviroc]]†, [[PRO 140]]†)
* ''[[CD4]]'' ([[Ibalizumab]]†)
* ''[[gp120]]'' ([[Fostemsavir]]†)

| group2 = [[Reverse-transcriptase inhibitor|Reverse-transcriptase inhibitors]] (RTIs)
| list2 =
{{Navbox subgroup

| group1 = [[Reverse transcriptase inhibitor|Nucleoside and nucleotide (NRTI)]]
| list1 =
* ''[[Nucleoside analogue]]s/[[Reverse transcriptase inhibitor#Nucleoside analog reverse transcriptase inhibitors .28NARTIs or NRTIs.29|NARTIs]]:'' [[Abacavir|Abacavir (ABC)]]°#
* [[Emtricitabine|Emtricitabine (FTC)]]°#
* [[Lamivudine|Lamivudine (3TC)]]°#
* [[Didanosine|Didanosine (ddI)]]#
* [[Zidovudine|Zidovudine (AZT, ZDV)]]#
* [[Apricitabine]]†
* [[Stampidine]]†
* [[Elvucitabine]]†
* [[Racivir]]†
* [[Amdoxovir]]†
* [[Stavudine|Stavudine (d4T)]]#
* [[Zalcitabine|Zalcitabine (ddC)]]◊
* [[Festinavir]]† 

*''[[Nucleotide analogue]]s/[[Reverse transcriptase inhibitor#Nucleotide analog reverse transcriptase inhibitors .28NtARTIs or NtRTIs.29|NtRTI]]s:'' [[Tenofovir disoproxil fumarate|Tenofovir disoproxil fumarate (TDF)]]°#
* [[Tenofovir alafenamide fumarate|Tenofovir alafenamide fumarate (TAF)]]†

| group2 = [[Reverse transcriptase inhibitor#Non-nucleoside reverse transcriptase inhibitors (NNRTIs)|Non-nucleoside (NNRTI)]] ''([[Discovery and development of non-nucleoside reverse transcriptase inhibitors|Discovery and development]])''
| list2 =
* ''(1st generation)'' [[Efavirenz|Efavirenz (EFV)]]°#
* [[Nevirapine|Nevirapine (NVP)]]#
* [[Delavirdine|Delavirdine (DLV)]]◊
* ''(2nd generation)'' ''[[diarylpyrimidines]]'' ([[Etravirine|Etravirine (ETR)]]
* [[Rilpivirine|Rilpivirine (RPV)]]°)
* [[Doravirine]]

}}
| group3 = [[Integrase inhibitor]]s
| list3 =
* [[Raltegravir|Raltegravir (RAL)]]°
* [[Elvitegravir|Elvitegravir (EVG)]]°
* [[Dolutegravir|Dolutegravir (DTG)]]°
* [[Globoidnan A]] (experimental)
* [[MK-2048]]†
* [[BI 224436]]†
* [[GSK744|Cabotegravir]]†  
| group4 = [[Maturation inhibitor]]s
| list4 =
* [[Bevirimat]]†

| group5 = [[Protease inhibitor (pharmacology)|Protease Inhibitors (PI)]]''([[Discovery and development of HIV protease inhibitors|Discovery and development]])''
| list5 =

{{Navbox subgroup

| group1 = 1st generation
| list1 =
* [[Fosamprenavir|Fosamprenavir (FPV)]]
* [[Lopinavir|Lopinavir (LPV)]]°#
* [[Nelfinavir|Nelfinavir (NFV)]]#
* [[Ritonavir|Ritonavir (RTV)]]#
* [[Saquinavir|Saquinavir (SQV)]]#
* [[Amprenavir|Amprenavir (APV)]]◊
* [[Indinavir|Indinavir (IDV)]]◊#
*[[Telinavir]]
*[[Droxinavir]]
| group2 =2nd generation
| list2 =
* [[Atazanavir|Atazanavir (ATV)]]°
* [[Darunavir|Darunavir (DRV)]]°
* [[Tipranavir|Tipranavir (TPV)]] 
}}

| group6 = [[Fixed-dose combination (antiretroviral)|Combined formulations]]
| list6 =
* [[Lamivudine/zidovudine]]
* [[Lopinavir/ritonavir]]°
* [[Abacavir/lamivudine/zidovudine]]
* [[Abacavir/lamivudine]]°
* [[Tenofovir/emtricitabine]]°
* [[Emtricitabine/tenofovir/efavirenz]]°
* [[Emtricitabine/rilpivirine/tenofovir]]°
* [[Elvitegravir/cobicistat/emtricitabine/tenofovir]]°
* [[Abacavir/dolutegravir/lamivudine]]°
* [[Atazanavir/cobicistat]]
* [[Darunavir/cobicistat]]
* [[Lamivudine/raltegravir]]

| group7 = Boosters
| list7 =
* [[Ritonavir|Ritonavir (r)]]
* [[Cobicistat|Cobicistat (cobi)]]

| group8 = Experimental agents
| list8 =
{{Navbox subgroup

| group1 = [[Antiviral drug#Uncoating inhibitor|Uncoating inhibitor]]s
| list1 =
* [[TRIM5alpha]] (gene)

| group2 = [[Transcription (genetics)|Transcription inhibitor]]s
| list2 =
* [[Tat (HIV)#Clinical significance|Tat antagonist]]s

| group3 = [[Antiviral drug#Translation .2F ribozymes|Translation inhibitor]]s
| list3 =
* [[Trichosanthin]]

| group4 = Other
| list4 =
* [[Abzyme]]
* [[Calanolide A]]
* [[Ceragenin]]
* [[Cyanovirin-N]]
* [[Diarylpyrimidines]]
* [[Epigallocatechin gallate|Epigallocatechin gallate (EGCG)]]
* [[Foscarnet]]
* [[Griffithsin]]
* [[Hydroxycarbamide]]
* [[Miltefosine]]
* [[Portmanteau inhibitor]]s
* [[Scytovirin]]
* [[Seliciclib]]†
* [[Synergistic enhancer (antiretroviral)|Synergistic enhancer]]s
* [[Tre recombinase]]
* [[Zinc finger protein transcription factor]]
* [[Error catastrophe#KP-1461|KP-1461]]†
* [[BIT225]]†
| group5 = Failed agents
| list5 =
* [[Aplaviroc]]
* [[Atevirdine]]
* [[Brecanavir]]
* [[Capravirine]]
* [[Dexelvucitabine]]
* [[Emivirine]]
* [[Lersivirine]]
* [[Lodenosine]]
* [[Loviride]]
}}

|belowstyle = background: transparent; padding: 0px;
|below = {{PharmNavFootnote}} °[[United States Department of Health and Human Services|DHHS]] ''recommended'' [[first-line treatment|initial regimen options]]. ◊Formerly or rarely used agent. {{Virus navs}}
}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by ATC]]
[[Category:Antiretroviral drugs]]
</noinclude>

Template:Antiretroviral drug

2015-02-25T16:54:40Z

62.192.250.172:

{{Navbox
| name = Antiretroviral drug
| title = [[Antiviral drug]]s: [[antiretroviral drug]]s used against [[HIV]] (primarily [[ATC code J05|J05]])
|listclass = hlist
|state = {{{state<includeonly>|autocollapse</includeonly>}}}

| group1 = [[Entry inhibitor|Entry/fusion inhibitors]] ''([[Discovery and development of CCR5 receptor antagonists|Discovery and development]])''
| list1 =
* ''[[gp41]]'' ([[Enfuvirtide|Enfuvirtide (ENF, T-20)]])
* ''[[CCR5]]'' ([[Maraviroc|Maraviroc (MVC)]]
* [[Vicriviroc]]†, [[Cenicriviroc]]†, [[PRO 140]]†)
* ''[[CD4]]'' ([[Ibalizumab]]†)
* ''[[gp120]]'' ([[Fostemsavir]]†)

| group2 = [[Reverse-transcriptase inhibitor|Reverse-transcriptase inhibitors]] (RTIs)
| list2 =
{{Navbox subgroup

| group1 = [[Reverse transcriptase inhibitor|Nucleoside and nucleotide (NRTI)]]
| list1 =
* ''[[Nucleoside analogue]]s/[[Reverse transcriptase inhibitor#Nucleoside analog reverse transcriptase inhibitors .28NARTIs or NRTIs.29|NARTIs]]:'' [[Abacavir|Abacavir (ABC)]]°#
* [[Emtricitabine|Emtricitabine (FTC)]]°#
* [[Lamivudine|Lamivudine (3TC)]]°#
* [[Didanosine|Didanosine (ddI)]]#
* [[Zidovudine|Zidovudine (AZT, ZDV)]]#
* [[Apricitabine]]†
* [[Stampidine]]†
* [[Elvucitabine]]†
* [[Racivir]]†
* [[Amdoxovir]]†
* [[Stavudine|Stavudine (d4T)]]#
* [[Zalcitabine|Zalcitabine (ddC)]]◊
* [[Festinavir]]† 

*''[[Nucleotide analogue]]s/[[Reverse transcriptase inhibitor#Nucleotide analog reverse transcriptase inhibitors .28NtARTIs or NtRTIs.29|NtRTI]]s:'' [[Tenofovir disoproxil fumarate|Tenofovir disoproxil fumarate (TDF)]]°#
* [[Tenofovir alafenamide fumarate|Tenofovir alafenamide fumarate (TAF)]]†

| group2 = [[Reverse transcriptase inhibitor#Non-nucleoside reverse transcriptase inhibitors (NNRTIs)|Non-nucleoside (NNRTI)]] ''([[Discovery and development of non-nucleoside reverse transcriptase inhibitors|Discovery and development]])''
| list2 =
* ''(1st generation)'' [[Efavirenz|Efavirenz (EFV)]]°#
* [[Nevirapine|Nevirapine (NVP)]]#
* [[Delavirdine|Delavirdine (DLV)]]◊
* ''(2nd generation)'' ''[[diarylpyrimidines]]'' ([[Etravirine|Etravirine (ETR)]]
* [[Rilpivirine|Rilpivirine (RPV)]]°)
* [[Doravirine]]

}}
| group3 = [[Integrase inhibitor]]s
| list3 =
* [[Raltegravir|Raltegravir (RAL)]]°
* [[Elvitegravir|Elvitegravir (EVG)]]°
* [[Dolutegravir|Dolutegravir (DTG)]]°
* [[Globoidnan A]] (experimental)
* [[MK-2048]]†
* [[BI 224436]]†
* [[GSK744|Cabotegravir]]†  
| group4 = [[Maturation inhibitor]]s
| list4 =
* [[Bevirimat]]†

| group5 = [[Protease inhibitor (pharmacology)|Protease Inhibitors (PI)]]''([[Discovery and development of HIV protease inhibitors|Discovery and development]])''
| list5 =

{{Navbox subgroup

| group1 = 1st generation
| list1 =
* [[Fosamprenavir|Fosamprenavir (FPV)]]
* [[Lopinavir|Lopinavir (LPV)]]°#
* [[Nelfinavir|Nelfinavir (NFV)]]#
* [[Ritonavir|Ritonavir (RTV)]]#
* [[Saquinavir|Saquinavir (SQV)]]#
* [[Amprenavir|Amprenavir (APV)]]◊
* [[Indinavir|Indinavir (IDV)]]◊#
*[[Telinavir]]
*[[Droxinavir]]
| group2 =2nd generation
| list2 =
* [[Atazanavir|Atazanavir (ATV)]]°
* [[Darunavir|Darunavir (DRV)]]°
* [[Tipranavir|Tipranavir (TPV)]] 
}}

| group6 = [[Fixed-dose combination (antiretroviral)|Combined formulations]]
| list6 =
* [[Lamivudine/zidovudine]]
* [[Emtricitabine/tenofovir/efavirenz]]°
* [[Abacavir/lamivudine/zidovudine]]
* [[Tenofovir/emtricitabine]]°
* [[Lopinavir/ritonavir]]°
* [[Abacavir/lamivudine]]°
* [[Emtricitabine/rilpivirine/tenofovir]]°
* [[Elvitegravir/cobicistat/emtricitabine/tenofovir]]°
* [[Abacavir/dolutegravir/lamivudine]]°

| group7 = Boosters
| list7 =
* [[Ritonavir|Ritonavir (r)]]
* [[Cobicistat|Cobicistat (cobi)]]

| group8 = Experimental agents
| list8 =
{{Navbox subgroup

| group1 = [[Antiviral drug#Uncoating inhibitor|Uncoating inhibitor]]s
| list1 =
* [[TRIM5alpha]] (gene)

| group2 = [[Transcription (genetics)|Transcription inhibitor]]s
| list2 =
* [[Tat (HIV)#Clinical significance|Tat antagonist]]s

| group3 = [[Antiviral drug#Translation .2F ribozymes|Translation inhibitor]]s
| list3 =
* [[Trichosanthin]]

| group4 = Other
| list4 =
* [[Abzyme]]
* [[Calanolide A]]
* [[Ceragenin]]
* [[Cyanovirin-N]]
* [[Diarylpyrimidines]]
* [[Epigallocatechin gallate|Epigallocatechin gallate (EGCG)]]
* [[Foscarnet]]
* [[Griffithsin]]
* [[Hydroxycarbamide]]
* [[Miltefosine]]
* [[Portmanteau inhibitor]]s
* [[Scytovirin]]
* [[Seliciclib]]†
* [[Synergistic enhancer (antiretroviral)|Synergistic enhancer]]s
* [[Tre recombinase]]
* [[Zinc finger protein transcription factor]]
* [[Error catastrophe#KP-1461|KP-1461]]†
* [[BIT225]]†
| group5 = Failed agents
| list5 =
* [[Aplaviroc]]
* [[Atevirdine]]
* [[Brecanavir]]
* [[Capravirine]]
* [[Dexelvucitabine]]
* [[Emivirine]]
* [[Lersivirine]]
* [[Lodenosine]]
* [[Loviride]]
}}

|belowstyle = background: transparent; padding: 0px;
|below = {{PharmNavFootnote}} °[[United States Department of Health and Human Services|DHHS]] ''recommended'' [[first-line treatment|initial regimen options]]. ◊Formerly or rarely used agent. {{Virus navs}}
}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by ATC]]
[[Category:Antiretroviral drugs]]
</noinclude>

Template:Drugs for peptic ulcer and GORD

2015-02-25T11:35:45Z

62.192.250.172:

{{Navbox
| name = Drugs for peptic ulcer and GORD
| title = Drugs for [[peptic ulcer]] and [[Gastroesophageal reflux disease|GERD/GORD]] ([[ATC_code_A02#A02B|A02B]])
| state = {{{state|autocollapse}}}
|listclass = hlist

| group1 = [[H2 antagonist|H2 antagonists]] ("-tidine")
| list1 =
* [[Cimetidine]]
* [[Famotidine]]
* [[Lafutidine]]
* [[Loxtidine]]
* [[Niperotidine]]
* [[Nizatidine]]
* [[Ranitidine]]
* [[Roxatidine]]

| group2 = [[Prostaglandin]]s (E)/[[Prostaglandin analogue|analogue]]s ("-prost-")
| list2 =
* [[Misoprostol]]
* [[Enprostil]]

| group3 = [[Proton-pump inhibitor]]s ("-prazole")
| list3 =
* [[Dexlansoprazole]]
* [[Esomeprazole]]
* [[Ilaprazole]]
* [[Lansoprazole]]
* [[Omeprazole]]
* [[Pantoprazole]]
*[[Picoprazole]]
* [[Rabeprazole]]
* [[Tenatoprazole]]
*[[Timoprazole]]

| group4 = Potassium-competitive acid blockers ("-prazan")
| list4 =
* [[Linaprazan]]
* [[Revaprazan]]
* [[Soraprazan]]
* [[Vonoprazan]]

| group5 = Other
| list5 =
* [[Acetoxolone]]
* [[Alginic acid]]
* [[Arbaclofen placarbil]]
* [[Carbenoxolone]]
* [[Cetraxate]]
* [[Gefarnate]]
* [[Lesogaberan]]
* [[Pirenzepine]]
* [[Proglumide]]
* [[Rebamipide]]
* [[Sucralfate]]
* [[Sulglicotide]]
* [[Telenzepine]]
* [[Teprenone]]
* [[Troxipide]]
* [[Zolimidine]]

| list6 =
* ''See also: [[Helicobacter pylori eradication protocols|''Helicobacter pylori'' eradication protocols]]''

| belowstyle = background: transparent; padding: 0px;
| below = {{Digestive system navs}}

}}<noinclude>
{{collapsible option}}
[[Category:Drugs for acid-related disorders]]
[[Category:Drug templates by ATC]]

</noinclude>

Template:Chemotherapeutic agents

2014-12-28T09:39:00Z

62.192.250.172:

{{Navbox
| name = Intracellular chemotherapeutic agents
|state = {{{state<includeonly>|collapsed</includeonly>}}}
| title = Intracellular [[Chemotherapy|chemotherapeutic agents]] / [[Antineoplastic|antineoplastic agents]] ([[ATC code L01|L01]])
|listclass = hlist
| groupstyle = background-color: #E5BFE5

| group1 = [[Spindle poison|SP]]s/[[mitotic inhibitor|MI]]s ([[M phase]])
| list1 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = Block [[microtubule]] assembly
| list1 =
* ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]#
* [[Vincristine]]#
* [[Vinflunine]]§
* [[Vindesine]]
* [[Vinorelbine]])

| group2 = Block microtubule disassembly
| list2 =
* ''[[Taxane]]s'' ([[Cabazitaxel]]
* [[Docetaxel]]#
* [[Larotaxel]]
* [[Ortataxel]]†
* [[Paclitaxel]]#
* [[Tesetaxel]])
* ''[[Epothilone]]s'' ([[Ixabepilone]])

}}

| group2 = [[DNA replication]] inhibitor
| list2 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = DNA precursors/ [[antimetabolite]]s ([[S phase]])
| list1 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Antifolate|Folic acid]]
| list1 =
* ''[[Dihydrofolate reductase inhibitor]]'' ([[Aminopterin]]
* [[Methotrexate]]#
* [[Pemetrexed]]
* [[Pralatrexate]])
* ''[[Thymidylate synthase inhibitor]]'' ([[Raltitrexed]]
* [[Pemetrexed]])

| group2 = [[Purine analogue|Purine]]
| list2 =
* ''[[Adenosine deaminase inhibitor]]'' ([[Pentostatin]])

*''[[Halogenation|Halogenated]]/[[ribonucleotide reductase inhibitor]]s'' ([[Cladribine]]
* [[Clofarabine]]
* [[Fludarabine]])
* [[Nelarabine]] 

*''[[Thiopurine]]'' ([[Tioguanine|Thioguanine]]#
* [[Mercaptopurine]]#)

|group3 = [[Pyrimidine analogue|Pyrimidine]]
|list3 =
* ''[[Thymidylate synthase inhibitor]]'' ([[Fluorouracil]]#
* [[Capecitabine]]
* [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])
* [[Carmofur]]
* [[Floxuridine]])

*''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]#)

*''[[Ribonucleotide reductase inhibitor]]'' ([[Gemcitabine]])

*''[[Hypomethylating agent]]'' ([[Azacitidine]]
* [[Decitabine]])

|group4 = [[Deoxyribonucleotide]]
|list4 =
* ''[[Ribonucleotide reductase inhibitor]]'' ([[Hydroxycarbamide]])

}}

| group2 = [[Topoisomerase inhibitor]]s ([[S phase]])
| list2 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Type I topoisomerase#Inhibition|I]]
| list1 =
* ''[[Camptotheca]]'' ([[Camptothecin]]
* [[Topotecan]]
* [[Irinotecan]]
* [[Rubitecan]]‡
* [[Belotecan]])

| group2 = [[Type II topoisomerase#Inhibition|II]]
| list2 =
* ''[[Podophyllum peltatum|Podophyllum]]'' ([[Etoposide]]#
* [[Teniposide]])

| group3 = [[Type II topoisomerase#Inhibition|II]]+[[Intercalation (chemistry)|Intercalation]]
| list3 =
* ''[[Anthracycline]]s'' ([[Aclarubicin]]
* [[Daunorubicin]]#
* [[Doxorubicin]]#
* [[Epirubicin]]
* [[Idarubicin]]
* [[Amrubicin]]†
* [[Pirarubicin]]
* [[Valrubicin]]
* [[Zorubicin]])
* ''[[Anthraquinone|Anthracenedione]]s'' ([[Mitoxantrone]]
* [[Pixantrone]])

}}

| group3 = [[Crosslinking of DNA]] ([[cell-cycle nonspecific antineoplastic agents|CCNS]])
| list3 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Alkylating antineoplastic agent|Alkylating]]
| list1 =
* ''[[Nitrogen mustard]]s:'' [[Mechlorethamine]]
* [[Cyclophosphamide]]# ([[Ifosfamide]]
* [[Trofosfamide]])
* [[Chlorambucil]]# ([[Melphalan]]
* [[Prednimustine]])
* [[Bendamustine]]
* [[Uramustine]]
* [[Estramustine]]

*''[[Nitrosourea]]s:'' [[Carmustine]]
* [[Lomustine]] ([[Semustine]])
* [[Fotemustine]]
* [[Nimustine]]
* [[Ranimustine]]
* [[Streptozotocin|Streptozocin]]

*''[[Alkyl sulfonate]]s:'' [[Busulfan]] ([[Mannosulfan]]
* [[Treosulfan]])

*''[[Aziridine]]s:'' [[Carboquone]]
* [[ThioTEPA]]
* [[Triaziquone]]
* [[Triethylenemelamine]]

| group2 = [[Platinum-based antineoplastic|Platinum-based]]
| list2 =
* [[Carboplatin]]
* [[Cisplatin]]
* [[Nedaplatin]]
* [[Oxaliplatin]]
* [[Satraplatin]]

|group3 = [[Alkylating_antineoplastic_agent#Nonclassical|Nonclassical]]
|list3 =
* ''[[Hydrazine]]s'' ([[Procarbazine]]#)
* ''[[Triazene]]s'' ([[Dacarbazine]]#
* [[Temozolomide]])
* [[Altretamine]]
* [[Mitobronitol]]
* [[Pipobroman]]

|group4 = [[Intercalation (chemistry)|Intercalation]]
|list4 =
* [[Streptomyces]] ([[Actinomycin]]#
* [[Bleomycin]]#
* [[Mitomycin]]
* [[Plicamycin]])

}}

}}

| group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]]
| list4 =
* [[D-Aminolevulinic acid|Aminolevulinic acid]] / [[Methyl aminolevulinate]]
* [[Efaproxiral]]
* ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]]
* [[Talaporfin]]
* [[Temoporfin]]
* [[Verteporfin]])

| group5 = Other
| list5 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Enzyme inhibitor]]s
| list1 =
* ''[[Farnesyltransferase inhibitor|FI]]'' ([[Tipifarnib]]§)
* ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]]†
* [[Seliciclib]]†)
* ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]]
* [[Carfilzomib]])
* ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])
* ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurin]]§)
* ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]])
* ''[[PARP inhibitor]]'' ([[Olaparib]])
* ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Belinostat]]
* [[Panobinostat]]
* [[Romidepsin]]
* [[Vorinostat]])
* ''[[Phosphoinositide 3-kinase inhibitor|PIKI]]'' ([[Idelalisib]])

| group2 = [[Receptor antagonist]]s
| list2 =
* ''[[Endothelin receptor antagonist|ERA]]'' ([[Atrasentan]])
* ''[[Retinoid X receptor]]'' ([[Bexarotene]])
* ''[[Sex steroid]]'' ([[Testolactone]])

|group3 = Other/ungrouped
|list3 =
* [[Amsacrine]]
* [[Trabectedin]]
* ''[[Retinoid]]s'' ([[Alitretinoin]]
* [[Tretinoin]])
* [[Arsenic trioxide]]
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]#/[[Pegaspargase]])
* [[Celecoxib]]
* [[Demecolcine]]
* [[Elesclomol]]§
* [[Elsamitrucin]]
* [[Etoglucid]]
* [[Lonidamine]]
* [[Lucanthone]]
* [[Mitoguazone]]
* [[Mitotane]]
* [[Oblimersen]]†
* [[Omacetaxine mepesuccinate]]
* [[Eribulin]]
}}

| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}{{Neoplasia navs}}

}}<noinclude>
{{collapsible option}}
[[Category:Antineoplastic drugs]]
[[Category:Drug_templates by ATC]]
[[Category:Oncology templates]]

[[ru:Шаблон:АТХ код L01]]
</noinclude>

Template:Chemotherapeutic agents

2014-12-28T09:36:43Z

62.192.250.172:

{{Navbox
| name = Intracellular chemotherapeutic agents
|state = {{{state<includeonly>|collapsed</includeonly>}}}
| title = Intracellular [[Chemotherapy|chemotherapeutic agents]] / [[Antineoplastic|antineoplastic agents]] ([[ATC code L01|L01]])
|listclass = hlist
| groupstyle = background-color: #E5BFE5

| group1 = [[Spindle poison|SP]]s/[[mitotic inhibitor|MI]]s ([[M phase]])
| list1 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = Block [[microtubule]] assembly
| list1 =
* ''[[Catharanthus#Vinca alkaloids|Vinca alkaloid]]s'' ([[Vinblastine]]#
* [[Vincristine]]#
* [[Vinflunine]]§
* [[Vindesine]]
* [[Vinorelbine]])

| group2 = Block microtubule disassembly
| list2 =
* ''[[Taxane]]s'' ([[Cabazitaxel]]
* [[Docetaxel]]#
* [[Larotaxel]]
* [[Ortataxel]]†
* [[Paclitaxel]]#
* [[Tesetaxel]])
* ''[[Epothilone]]s'' ([[Ixabepilone]])

}}

| group2 = [[DNA replication]] inhibitor
| list2 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = DNA precursors/ [[antimetabolite]]s ([[S phase]])
| list1 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Antifolate|Folic acid]]
| list1 =
* ''[[Dihydrofolate reductase inhibitor]]'' ([[Aminopterin]]
* [[Methotrexate]]#
* [[Pemetrexed]]
* [[Pralatrexate]])
* ''[[Thymidylate synthase inhibitor]]'' ([[Raltitrexed]]
* [[Pemetrexed]])

| group2 = [[Purine analogue|Purine]]
| list2 =
* ''[[Adenosine deaminase inhibitor]]'' ([[Pentostatin]])

*''[[Halogenation|Halogenated]]/[[ribonucleotide reductase inhibitor]]s'' ([[Cladribine]]
* [[Clofarabine]]
* [[Fludarabine]])
* [[Nelarabine]] 

*''[[Thiopurine]]'' ([[Tioguanine|Thioguanine]]#
* [[Mercaptopurine]]#)

|group3 = [[Pyrimidine analogue|Pyrimidine]]
|list3 =
* ''[[Thymidylate synthase inhibitor]]'' ([[Fluorouracil]]#
* [[Capecitabine]]
* [[Tegafur]] ([[Tegafur/gimeracil/oteracil|+gimeracil/oteracil]])
* [[Carmofur]]
* [[Floxuridine]])

*''[[DNA polymerase inhibitor]]'' ([[Cytarabine]]#)

*''[[Ribonucleotide reductase inhibitor]]'' ([[Gemcitabine]])

*''[[Hypomethylating agent]]'' ([[Azacitidine]]
* [[Decitabine]])

|group4 = [[Deoxyribonucleotide]]
|list4 =
* ''[[Ribonucleotide reductase inhibitor]]'' ([[Hydroxycarbamide]])

}}

| group2 = [[Topoisomerase inhibitor]]s ([[S phase]])
| list2 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Type I topoisomerase#Inhibition|I]]
| list1 =
* ''[[Camptotheca]]'' ([[Camptothecin]]
* [[Topotecan]]
* [[Irinotecan]]
* [[Rubitecan]]‡
* [[Belotecan]])

| group2 = [[Type II topoisomerase#Inhibition|II]]
| list2 =
* ''[[Podophyllum peltatum|Podophyllum]]'' ([[Etoposide]]#
* [[Teniposide]])

| group3 = [[Type II topoisomerase#Inhibition|II]]+[[Intercalation (chemistry)|Intercalation]]
| list3 =
* ''[[Anthracycline]]s'' ([[Aclarubicin]]
* [[Daunorubicin]]#
* [[Doxorubicin]]#
* [[Epirubicin]]
* [[Idarubicin]]
* [[Amrubicin]]†
* [[Pirarubicin]]
* [[Valrubicin]]
* [[Zorubicin]])
* ''[[Anthraquinone|Anthracenedione]]s'' ([[Mitoxantrone]]
* [[Pixantrone]])

}}

| group3 = [[Crosslinking of DNA]] ([[cell-cycle nonspecific antineoplastic agents|CCNS]])
| list3 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Alkylating antineoplastic agent|Alkylating]]
| list1 =
* ''[[Nitrogen mustard]]s:'' [[Mechlorethamine]]
* [[Cyclophosphamide]]# ([[Ifosfamide]]
* [[Trofosfamide]])
* [[Chlorambucil]]# ([[Melphalan]]
* [[Prednimustine]])
* [[Bendamustine]]
* [[Uramustine]]
* [[Estramustine]]

*''[[Nitrosourea]]s:'' [[Carmustine]]
* [[Lomustine]] ([[Semustine]])
* [[Fotemustine]]
* [[Nimustine]]
* [[Ranimustine]]
* [[Streptozotocin|Streptozocin]]

*''[[Alkyl sulfonate]]s:'' [[Busulfan]] ([[Mannosulfan]]
* [[Treosulfan]])

*''[[Aziridine]]s:'' [[Carboquone]]
* [[ThioTEPA]]
* [[Triaziquone]]
* [[Triethylenemelamine]]

| group2 = [[Platinum-based antineoplastic|Platinum-based]]
| list2 =
* [[Carboplatin]]
* [[Cisplatin]]
* [[Nedaplatin]]
* [[Oxaliplatin]]
* [[Satraplatin]]

|group3 = [[Alkylating_antineoplastic_agent#Nonclassical|Nonclassical]]
|list3 =
* ''[[Hydrazine]]s'' ([[Procarbazine]]#)
* ''[[Triazene]]s'' ([[Dacarbazine]]#
* [[Temozolomide]])
* [[Altretamine]]
* [[Mitobronitol]]
* [[Pipobroman]]

|group4 = [[Intercalation (chemistry)|Intercalation]]
|list4 =
* [[Streptomyces]] ([[Actinomycin]]#
* [[Bleomycin]]#
* [[Mitomycin]]
* [[Plicamycin]])

}}

}}

| group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]]
| list4 =
* [[D-Aminolevulinic acid|Aminolevulinic acid]] / [[Methyl aminolevulinate]]
* [[Efaproxiral]]
* ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]]
* [[Talaporfin]]
* [[Temoporfin]]
* [[Verteporfin]])

| group5 = Other
| list5 = {{Navbox subgroup
| groupstyle = background-color: #E5BFE5

| group1 = [[Enzyme inhibitor]]s
| list1 =
* ''[[Farnesyltransferase inhibitor|FI]]'' ([[Tipifarnib]])
* ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]]†
* [[Seliciclib]]†)
* ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]]
* [[Carfilzomib]])
* ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])
* ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurin]]§)
* ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]])
* ''[[PARP inhibitor]]'' ([[Olaparib]])
* ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Belinostat]]
* [[Panobinostat]]
* [[Romidepsin]]
* [[Vorinostat]])
* ''[[Phosphoinositide 3-kinase inhibitor|PIKI]]'' ([[Idelalisib]])

| group2 = [[Receptor antagonist]]s
| list2 =
* ''[[Endothelin receptor antagonist|ERA]]'' ([[Atrasentan]])
* ''[[Retinoid X receptor]]'' ([[Bexarotene]])
* ''[[Sex steroid]]'' ([[Testolactone]])

|group3 = Other/ungrouped
|list3 =
* [[Amsacrine]]
* [[Trabectedin]]
* ''[[Retinoid]]s'' ([[Alitretinoin]]
* [[Tretinoin]])
* [[Arsenic trioxide]]
* ''[[Asparagine|Asparagine depleter]]s'' ([[Asparaginase]]#/[[Pegaspargase]])
* [[Celecoxib]]
* [[Demecolcine]]
* [[Elesclomol]]§
* [[Elsamitrucin]]
* [[Etoglucid]]
* [[Lonidamine]]
* [[Lucanthone]]
* [[Mitoguazone]]
* [[Mitotane]]
* [[Oblimersen]]†
* [[Omacetaxine mepesuccinate]]
* [[Eribulin]]
}}

| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}{{Neoplasia navs}}

}}<noinclude>
{{collapsible option}}
[[Category:Antineoplastic drugs]]
[[Category:Drug_templates by ATC]]
[[Category:Oncology templates]]

[[ru:Шаблон:АТХ код L01]]
</noinclude>